SAM
AXSM icon

Sectoral Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Sectoral Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Hold
1,500
– – 0.26% 67
2026
Q1 		$290K Sell
1,500
-240
-14% -$41.5K 0.24% 71
2025
Q4 		$318K Buy
1,740
+720
+71% +$101K 0.25% 69
2025
Q3 		$124K Hold
1,020
– – 0.08% 81
2025
Q2 		$106K Hold
1,020
– – 0.07% 93
2025
Q1 		$119K Buy
1,020
+200
+24% +$22.8K 0.09% 77
2024
Q4 		$69.4K Buy
+820
New +$75.4K 0.05% 85
2020
Q3 		– Sell
-4,200
Closed -$346K – 99
2020
Q2 		$346K Buy
+4,200
New +$323K 0.03% 153

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sectoral Asset Management's AXSM Position: Q2 2026 in Review

Sectoral Asset Management held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 1,500 shares worth $367K. The position accounts for 0.26% of the portfolio, ranked #67.

Sectoral Asset Management first reported a position in AXSM in Q2 2020 and has held it in 8 quarters since. 505 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Sectoral Asset Management held 1,500 shares of Axsome Therapeutics worth $367K as of Q2 2026.
  • Sectoral Asset Management left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up 0.26% of Sectoral Asset Management's portfolio in Q2 2026, its #67 holding.
  • Sectoral Asset Management first reported a position in Axsome Therapeutics in Q2 2020 and has held it in 8 quarters since.
  • 505 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.